TD Cowen analyst Gary Taylor raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $17 and keeps a Buy rating on the shares. The firm updated its model following Q3 results as they raised their guidance for the fourth consecutive quarter since Q3 2024.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare’s Earnings Call Highlights Strong Growth
- Strong Buy Rating Backed by Consistent EBITDA Growth and Strategic Expansion
- Alignment Healthcare price target raised to $18 from $13 at Barclays
- Alignment Healthcare price target raised to $18 from $17 at UBS
- Alignment Healthcare Surpasses Q3 2025 Financial Expectations